The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EKSO | +49.24% | -87.89% | -34.45% | -100% |
| S&P | +18.89% | +78.8% | +12.32% | +272% |
Ekso Bionics Holdings, Inc. engages in the design, development and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following segments: EksoHealth and EksoWorks. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in San Rafael, CA.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $3.14M | -38.3% |
| Gross Profit | $1.67M | -38.4% |
| Gross Margin | 53.22% | -0.1% |
| Market Cap | $29.31M | 116.4% |
| Market Cap / Employee | $532.97K | 0.0% |
| Employees | 55 | -9.8% |
| Net Income | -$4,674.00K | -36.9% |
| EBITDA | -$4,058.00K | -121.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.17M | -82.0% |
| Accounts Receivable | $7.31M | 1.0% |
| Inventory | 4.8 | 5.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $945.00K | -78.1% |
| Short Term Debt | $3.70M | 120.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -50.02% | -9.2% |
| Return On Invested Capital | -85.87% | 17.3% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4,457.00K | -206.5% |
| Operating Free Cash Flow | -$4,331.00K | -202.2% |
| Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.90 | 0.49 | 1.22 | 2.34 | 119.66% |
| Price to Sales | 0.58 | 0.49 | 0.91 | 2.01 | 139.97% |
| Price to Tangible Book Value | 17.44 | 0.78 | 2.13 | 4.45 | -78.40% |
| Enterprise Value to EBITDA | -2.55 | -2.03 | -15.12 | -7.20 | -9.12% |
| Return on Equity | -80.7% | -96.4% | -85.0% | -107.6% | 20.22% |
| Total Debt | $5.62M | $5.39M | $4.96M | $4.64M | -22.38% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
